2 October 2019
Meeting category
Date(s)
2 Oct 2019
Location
Washington DC,
United States
Managing Complex HIV Patients 2019
Related Enduring Materials
Enduring Materials
- 09:00
09:00 ET
Welcome and Opening
Jonathan Schapiro, MD
Sheba Medical Center, Israel
Managing Today’s Complex HIV Patient Satellite Symposium -
Chairs
Jonathan Schapiro, MD
Sheba Medical Center, Israel
Charles Boucher, MD, PhD
Erasmus Medical Center, the Netherlands
09:05 ET
How to Identify the Complex HIV Patient and Approach to Treatment
09:30 ET
Drug Options for the Complex HIV Patient: What Are They and How Best to Use Them?
Clinical Case Discussions - 09:55
09:55 ET
Clinical Case #1: Focus on Drug Resistance
10:15 ET
Clinical Case #2: Focus on Comorbidities and Toxicity
David Hardy, MD, AAHIVS
Johns Hopkins University School of Medicine, United States
10:50 ET
Summary and Take Home Messages
Jonathan Schapiro, MD
Sheba Medical Center, Israel
11:00 ET
End of Symposium
Overview
Welcome
The Symposium on Managing Today's Complex HIV Patients took place from 9:00-11:00 AM on 2 October 2019 in Washington, D.C. at IDWeek.
Needs Assessment
Despite improved antiretroviral regimens, virological failure and emergence of drug resistance is still a problem worldwide. This includes both patients recently infected and those veterans of older regimens. Overall, viral suppression among PLWHIV in the USA is 55% and adherence is often sub-optimal. Ultimately, this leads to an increasing number of HIV patients with limited treatment options. Patients with limited treatment options require greater knowledge and understanding to manage in terms of adherence, resistance, aging, comorbidities, and polypharmacy. Thus, they can be considered complex HIV patients. Many HIV-treating clinicians who have entered the field in the last decade have little knowledge of resistance and drug-drug interactions due to the ease at which first-line patients can often be prescribed. HIV physicians need to be educated in identifying and managing the complex HIV patient. HIV physicians need to be educated on new antiretroviral drugs for optimizing treatment of these complex HIV patients.
Program Directors
General Information
Meeting Objectives
Create an opportunity to educate HIV-treating clinicians on the optimal identification and management of complex patients, specifically addressing:
- Tools to properly identify patients in their practice that merit care as complex patients
- Resistance considerations
- Polypharmacy, drug-drug interactions, and comorbidities
- New treatment options and how best to integrate them into care
- Utilize interactive case-based discussion with expert clinicians knowledgeable on treating complex patients
- Tools to properly identify patients in their practice that merit care as complex patients
- Resistance considerations
- Polypharmacy, drug-drug interactions, and comorbidities
- New treatment options and how best to integrate them into care
- Utilize interactive case-based discussion with expert clinicians knowledgeable on treating complex patients
Learning Objectives
At the completion of the activity, participants will have:
- Improved knowledge of the definition on complex patients and the challenges of their care;
- Acquired tools and understanding on how best to Identify the complex HIV patient in their clinical practice;
- Greater understanding of the new treatment options available for these patients;
- Learned how best to integrate these new drugs in to optimal combination regimens; and
- Improved skills on managing drug-drug interactions and toxicities in these complex patients.
- Improved knowledge of the definition on complex patients and the challenges of their care;
- Acquired tools and understanding on how best to Identify the complex HIV patient in their clinical practice;
- Greater understanding of the new treatment options available for these patients;
- Learned how best to integrate these new drugs in to optimal combination regimens; and
- Improved skills on managing drug-drug interactions and toxicities in these complex patients.
Practical Information
Certificate of Attendance
A certificate of attendance was sent to participants that successfully completed the meeting and post-meeting survey.
Language
The official language of the meeting was English.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings were not permitted at the official meeting sessions. Only the official medical writer appointed by the organization was permitted to make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided that the speaker has given permission to do so.
Support
Support
This program has been made possible by an unrestricted educational grant from ViiV Healthcare.
Language
Related Programs
